A new trading day began on Tuesday, with Vir Biotechnology Inc (NASDAQ: VIR) stock price down -5.81% from the previous day of trading, before settling in for the closing price of $8.26. VIR’s price has ranged from $7.61 to $13.09 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 421.39% over the past five years. Meanwhile, its annual earnings per share averaged 26.24%. With a float of $87.95 million, this company’s outstanding shares have now reached $134.78 million.
Let’s look at the performance matrix of the company that is accounted for 587 employees. In terms of profitability, gross margin is 80.31%, operating margin of -673.27%, and the pretax margin is -682.39%.
Vir Biotechnology Inc (VIR) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Vir Biotechnology Inc is 35.64%, while institutional ownership is 51.03%. The most recent insider transaction that took place on Jun 11 ’24, was worth 43,789. In this transaction Director of this company sold 4,000 shares at a rate of $10.95, taking the stock ownership to the 14,619 shares. Before that another transaction happened on Apr 03 ’24, when Company’s Chief Executive Officer sold 72,995 for $9.46, making the entire transaction worth $690,365. This insider now owns 678,457 shares in total.
Vir Biotechnology Inc (VIR) Latest Financial update
In its latest quarterly report, released on 6/30/2024, the company reported earnings of -1.22 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.89 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 26.24% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 7.00% during the next five years compared to -34.12% drop over the previous five years of trading.
Vir Biotechnology Inc (NASDAQ: VIR) Trading Performance Indicators
Here are Vir Biotechnology Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 12.51. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 13.48.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.58, a number that is poised to hit -1.05 in the next quarter and is forecasted to reach -3.77 in one year’s time.
Technical Analysis of Vir Biotechnology Inc (VIR)
Vir Biotechnology Inc (NASDAQ: VIR) saw its 5-day average volume 0.51 million, a negative change from its year-to-date volume of 1.04 million. As of the previous 9 days, the stock’s Stochastic %D was 10.60%. Additionally, its Average True Range was 0.42.
During the past 100 days, Vir Biotechnology Inc’s (VIR) raw stochastic average was set at 3.10%, which indicates a significant increase from 0.83% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 43.50% in the past 14 days, which was lower than the 63.48% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.09, while its 200-day Moving Average is $9.69. Nevertheless, the first resistance level for the watch stands at $8.16 in the near term. At $8.55, the stock is likely to face the second major resistance level. The third major resistance level sits at $8.74. If the price goes on to break the first support level at $7.58, it is likely to go to the next support level at $7.39. The third support level lies at $7.00 if the price breaches the second support level.
Vir Biotechnology Inc (NASDAQ: VIR) Key Stats
With a market capitalization of 1.06 billion, the company has a total of 136,059K Shares Outstanding. Currently, annual sales are 86,180 K while annual income is -615,060 K. The company’s previous quarter sales were 3,080 K while its latest quarter income was -138,380 K.
